指南与共识甲状腺疾病

美国甲状腺协会指南与声明:过去、现在与未来

American Thyroid Association Guidelines and Statements: Past, Present, and Future.
指南 / 共识 · Thyroid · 2018-04-26

美国甲状腺协会指南政策与程序工作组于2017年回顾协会临床实践指南与声明的发布历史及现行政策,并借鉴其他机构经验。文章提出新指南与声明委员会需关注的六项未来议题,包括提升方法学严谨性、规范声明制定流程及管理利益冲突等。

要点

  • ATA指南与声明具有全球影响力,需持续改进方法学严谨性与透明度。
  • 未来需正式化新声明的制定框架与流程。
  • 应加强指南制定组成员利益冲突管理与多样性代表性。

核心结论

  • ATA在甲状腺疾病临床管理、教育和研究方面具有全球影响力,并致力于持续改进其出版物。
  • 工作组识别了实现持续改进目标的诸多要素及新委员会面临的挑战领域。

研究设计与样本

  • ATA指南政策与程序工作组于2017年活动,回顾ATA临床实践指南发布记录与现行政策。
  • 工作组审查其他组织政策,征求外部专家与组织意见,并召开五次电话会议和两次面对面会议。

主要发现

  • ATA拥有丰富的官方出版物历史,其影响力体现在下载量、引用记录及实践趋势变化上。
  • 新ATA指南与声明委员会需进一步解决的未来关键议题包括提升CPG制定方法学严谨性、正式化新声明框架、加强利益冲突管理透明度、鼓励公平与多样性、增加利益相关者代表性及扩展指南实施策略。

关键数值与推荐

  • 未来议题包括在可行性与时效性及透明沟通的专家意见作用之间取得平衡。
  • 未来议题包括提高CPG/声明小组成员利益冲突管理的严格性与透明度。
  • 未来议题包括鼓励CPG/声明制定组组成考虑公平与多样性。
  • 未来议题包括增加相关利益相关者(含患者代表)在CPG/声明制定中的代表性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Thyroid Association (ATA) is continually striving to improve the quality of its publications. The ATA Guidelines Policies and Procedures Task Force was active during 2017. It recently recommended convening a formal standing committee to review and update policies and procedures for the development of clinical practice guidelines (CPGs) and Statements on an ongoing basis. OBJECTIVE: This statement reviews the history of official ATA publications and discusses the challenges and findings identified by the Task Force. We also wish to present our "work in progress" and propose future directions for the new ATA Guidelines and Statements Committee (ATA GSC). METHODS: Our Task Force reviewed the publication record of the ATA with respect to CPGs. We also reviewed existing ATA policies for CPGs and other official statements, examined policies of other organizations, solicited input from external experts and organizations, and convened five conference calls and two in-person meetings. RESULTS: The ATA has a rich history of developing official publications that have been influential based on download and citation records as well as changes in practice trends. Key future issues to be further addressed by the ATA GSC include the following: (i) striving to improve the methodologic rigor of development of CPGs while balancing considerations of feasibility and timeliness and the role of transparently communicated expert opinion; (ii) formalizing a framework and process for development of new Statements; (iii) increasing stringency and transparency of management of competing interests of individuals being considered for CPG/Statement panel membership; (iv) encouraging consideration of equity and diversity in CPG/Statement development group composition; (v) increasing relevant stakeholder representation (including patient representatives) in development of CPGs/Statements; and (vi) expanding future guideline implementation strategies. CONCLUSIONS: As shown by the completed literature search, the ATA has a long history of producing CPGs and Statements with global impact on informing clinical management, education, and research in thyroid diseases. The ATA remains committed to a process of continual improvement of its publications and to meeting stakeholder information needs. Based on the work of our Task Force, we have identified many elements that are needed to achieve this goal and areas of challenge for our new committee.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Sawka AM, Carty SE, Haugen BR, et al. American Thyroid Association Guidelines and Statements: Past, Present, and Future. Thyroid. 2018. PMID: 29698130. doi:10.1089/thy.2018.0070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。